Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials Acta Neuropathol 127, 861–879 (2014). https://doi.org/10.1007/s00401-014-1256-4 Mandler, M., Valera, E., Rockenstein, E. et al. (2013)
Acta Neuropathol 127, 861–879 (2014). https://doi.org/10.1007/s00401-014-1256-4